Portola Pharmaceuticals (PTLA) jumps 130% with a very strong forecast ahead of it
What’s up with Portola Pharmaceuticals?
Portola Pharmaceuticals (PTLA) opened at $17.85, which means the stock is up 130.28% from yesterday’s closing price of 7.76. Today, the company has a high of $17.88 and a low of $17.71. The company has a market cap of $1.40 billion with a 52-week high of $36.98 and a 52-week low of $5.31.
What about the future for Portola Pharmaceuticals?
The high forecast for Portola Pharmaceuticals is 31.00 while the low is 9.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Portola Pharmaceuticals has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information PTLA seems to be a safe buy.
About Portola Pharmaceuticals
Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.